Detalhe da pesquisa
1.
Leptin-mediated meta-inflammation may provide survival benefit in patients receiving maintenance immunotherapy for extensive-stage small cell lung cancer (ES-SCLC).
Cancer Immunol Immunother
; 72(11): 3803-3812, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37668709